Sanofi, Regeneron say new cholesterol drug data positive
September 01, 2015 at 09:35 AM EDT
PARIS, Sept 1 (Reuters) - Sanofi and Regeneron Pharmaceuticals said on Tuesday that a study into their new cholesterol-lowering drug, Praluent, showed promising results.
